ArticleFrontiers in endocrinology2026

Baicalein inhibits the progression of thyroid cancer by suppressing the TPL2/MEK2/ERK2 pathway.

Nan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.